Menu

#Nordisk

14 posts

Feed·
7 of 14 posts
Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
🖼️
0Read More

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

US Top News and Analysis·1 day ago
#9noD4oDJ
#cnbc#business#supplements#health#market

Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.

15s
Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales
🖼️
0Read More

Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales

Bloomberg.com·Satviki Sanjay·6 months ago
#hqs4yhHV
#novonordiskasb#india#drugs#elilillyco#novo

Novo Nordisk A/S saw a 40% surge in sales of its diabetes and weight-loss drugs in India last month, after steep price cuts boosted demand for its branded treatments even as generic GLP-1 therapies flood the market.

15s
Novo Nordisk A/S (NOVO:CA) Q1 2026 Earnings Call Transcript
🖼️
0Read More

Novo Nordisk A/S (NOVO:CA) Q1 2026 Earnings Call Transcript

Seeking Alpha·SA Transcripts·6 months ago
#LpNoLAa4
#source#chevron#alpha#research#novo

Novo Nordisk A/S (NOVO:CA) Q1 2026 Earnings Call May 6, 2026 7:00 AM EDTCompany ParticipantsMichael Novod - Senior VP & Head of Investor RelationsMaziar...

15s